This content is machine translated Researchers discover new connection How a signaling molecule influences the clinical course of ovarian cancer Ovarian cancer is the fifth leading cause of cancer-related death in women, primarily because it is usually detected late, metastasizes early to the abdomen, and available therapeutic agents are usually…
View Post 5 min This content is machine translated Ovarian tumors Of PARP inhibitors, new agents and sexuality The treatment of ovarian cancer is in a constant state of flux with the ongoing development of new drugs such as PARP inhibitors. With increasing experience in the use of…
View Post 6 min This content is machine translated News from the world of oncology The hottest studies at a glance Every year, ESMO presents the most relevant research results of its congress within the framework of so-called Presidential Symposia. Also at this year’s virtual execution, the presentation of those studies…
View Post 1 min This content is machine translated BRCA-mutated advanced ovarian cancer. PARP inhibitor shows long-term benefit in terms of PFS Ovarian cancer is the eighth leading cause of death among women with cancer worldwide. In Switzerland, approximately 620 patients are newly diagnosed with ovarian cancer each year. Approximately 22% of…
View Post 3 min This content is machine translated Blood-brain barrier When breast cancer invades the brain Patients with breast cancer can develop metastases in the brain – which means an even worse chance of survival. There may be factors in the blood that can predict this…
View Post 1 min This content is machine translated Cystitis When going to the toilet becomes a pain! About 50-70% of all women have cystitis at least once a year. Repeated bladder infections occur in approximately 5-10% of cases. Phytotherapeutic preparations based on nasturtium and horseradish can provide…
View Post 3 min This content is machine translated Ovarian Cancer Updated S3 guideline recommends PARP inhibitors and radiotherapy Because ovarian cancer generally has no specific symptoms, it is often diagnosed at late stages. The mortality risk is correspondingly high. In order to provide affected women with optimal therapy,…
View Post 2 min This content is machine translated Multiple sclerosis Individual life situation in the focus of effective therapy Intensive research in the field of multiple sclerosis (MS) has led to the availability of different treatment options – depending on the form of the disease and its severity. Until…
View Post 3 min This content is machine translated Case report: Pregnancy and birth Von Willebrand syndrome with impressive bleeding history A patient who had already suffered four miscarriages related to bleeding complications presents for thrombophilia screening at the 6th week of gestation. During the diagnostic process, Von Willebrand syndrome is…
View Post 4 min This content is machine translated Sponsored Content Maintenance therapy in ovarian cancer: considerations in the era of COVID-19. Cancer patients are considered a high-risk group in the Corona pandemic. But does this mean that one should now do without certain treatments? Prof. Dr. med. Viola Heinzelmann-Schwarz, Gynecological Tumor…
View Post 2 min This content is machine translated Case report: Pregnancy Von Willebrand syndrome and anti-phospholipid syndrome A patient with anti-phospholipid syndrome undergoes fertility treatment because she had already suffered two miscarriages. During a laboratory examination at the beginning of pregnancy, Von Willebrand syndrome is also diagnosed.…
